These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38238014)

  • 1. Artificial Intelligence for Improved Patient Outcomes-The Pragmatic Randomized Controlled Trial Is the Secret Sauce.
    Byrne DW; Domenico HJ; Moore RP
    Korean J Radiol; 2024 Feb; 25(2):123-125. PubMed ID: 38238014
    [No Abstract]   [Full Text] [Related]  

  • 2. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
    Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
    J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
    Dal-Ré R; Janiaud P; Ioannidis JPA
    BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Realtime Diagnosis from Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation with Long Follow-Up (REGAL): Rationale and design of a pragmatic, decentralized, randomized controlled trial.
    Yao X; Attia ZI; Behnken EM; Hart MS; Inselman SA; Weber KC; Li F; Stricker NH; Stricker JL; Friedman PA; Noseworthy PA
    Am Heart J; 2024 Jan; 267():62-69. PubMed ID: 37913853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?
    van der Velden JM; Verkooijen HM; Young-Afat DA; Burbach JP; van Vulpen M; Relton C; van Gils CH; May AM; Groenwold RH
    Int J Epidemiol; 2017 Feb; 46(1):96-102. PubMed ID: 27118559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raising the Bar for Randomized Trials Involving Artificial Intelligence: The SPIRIT-Artificial Intelligence and CONSORT-Artificial Intelligence Guidelines.
    Taylor M; Liu X; Denniston A; Esteva A; Ko J; Daneshjou R; Chan AW;
    J Invest Dermatol; 2021 Sep; 141(9):2109-2111. PubMed ID: 33766511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.
    Anstrom KJ; Noth I; Flaherty KR; Edwards RH; Albright J; Baucom A; Brooks M; Clark AB; Clausen ES; Durheim MT; Kim DY; Kirchner J; Oldham JM; Snyder LD; Wilson AM; Wisniewski SR; Yow E; Martinez FJ;
    Respir Res; 2020 Mar; 21(1):68. PubMed ID: 32164673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of expertise-based pragmatic randomized controlled trial in acupuncture-moxibustion clinical research].
    Xu ZG; Ge SQ; Lu LM
    Zhongguo Zhen Jiu; 2020 May; 40(5):538-42. PubMed ID: 32394663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Clinical Trials of Artificial Intelligence in Medicine: Why, When, and How?
    Park SH; Choi JI; Fournier L; Vasey B
    Korean J Radiol; 2022 Dec; 23(12):1119-1125. PubMed ID: 36447410
    [No Abstract]   [Full Text] [Related]  

  • 10. Series: Pragmatic trials and real world evidence: Paper 5. Usual care and real life comparators.
    Zuidgeest MGP; Welsing PMJ; van Thiel GJMW; Ciaglia A; Alfonso-Cristancho R; Eckert L; Eijkemans MJC; Egger M;
    J Clin Epidemiol; 2017 Oct; 90():92-98. PubMed ID: 28694123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.
    Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M
    BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Opportunities and Challenges of Pragmatic Randomized Trials Using a Specialized Software: CloudTrials Project.
    Fosser SM; Kamozin A; McDonald EG; Tamblyn R; Lee TC
    Stud Health Technol Inform; 2019 Aug; 264():1544-1545. PubMed ID: 31438223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Pragmatic' or 'streamlined': Which term best fits the REMAP-CAP trial.
    Dal-Ré R
    Eur J Intern Med; 2023 Jul; 113():119-121. PubMed ID: 37030996
    [No Abstract]   [Full Text] [Related]  

  • 14. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
    Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R
    Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for clinical trials using artificial intelligence - SPIRIT-AI and CONSORT-AI
    McGenity C; Treanor D
    J Pathol; 2021 Jan; 253(1):14-16. PubMed ID: 33016344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework.
    Sharma T; Qamar I; Zwarenstein M
    J Clin Epidemiol; 2022 Dec; 152():193-200. PubMed ID: 36265553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience using pragmatic care trials to guide neurovascular practice under uncertainty.
    Darsaut TE; Raymond J
    Neurochirurgie; 2020 Dec; 66(6):423-428. PubMed ID: 33049287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis.
    Vanderhout S; Fergusson DA; Cook JA; Taljaard M
    PLoS Med; 2022 Feb; 19(2):e1003896. PubMed ID: 35134080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.